Related Experiment Video
Updated: Jun 26, 2026

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
A virtual screening study of the acetylcholine binding protein using a relaxed-complex approach
Arneh Babakhani1, Todd T Talley, Palmer Taylor
1Department of Chemistry & Biochemistry, University of California at San Diego, 9500 Gilman Dr MC 0365, La Jolla, CA 92093-0365, USA.
Researchers screened potential drug compounds against acetylcholine binding protein (AChBP) to find new ways to target nicotinic acetylcholine receptors (nAChRs). Novel ligands show promise for developing pharmaceuticals for nAChR-related neurological conditions.
Area of Science:
- Neuroscience
- Pharmacology
- Structural Biology
Background:
- Nicotinic acetylcholine receptors (nAChRs) are crucial ligand-gated ion channels involved in numerous neurological processes.
- High-resolution structures of nAChRs are challenging to obtain, hindering drug development.
- Acetylcholine binding protein (AChBP) structures provide a high-resolution surrogate for the extracellular domain of nAChRs.
Purpose of the Study:
- To virtually screen a diverse ligand library for potential binders of AChBP.
- To identify novel compounds that can modulate nAChR activity through AChBP interactions.
- To explore potential pharmaceutical applications for targeting nAChR-related neurological disorders.
Main Methods:
- Employed the relaxed-complex method, integrating molecular dynamics simulations and ligand docking.
- Utilized a virtual screening approach on the National Cancer Institute's ligand library.
- Assessed ligand binding affinity and specificity across various AChBP species and structures.
Main Results:
- Identified numerous ligands from the National Cancer Institute library with significant potential for binding AChBP.
- Observed that identified ligands mimic known AChBP binders and exhibit varied binding modes.
- A notable subset of ligands demonstrated effective docking against all tested AChBP species, with some showing selectivity.
Conclusions:
- The virtual screening successfully identified novel potential ligands for AChBP.
- These compounds represent promising candidates for pharmaceutical development targeting AChBP/nAChR systems.
- The findings offer new avenues for therapeutic strategies in neurological conditions associated with nAChRs.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
07:22The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
Published on: January 12, 2024